Εισάγετε μια λέξη ή φράση σε οποιαδήποτε γλώσσα 👆
Γλώσσα:
Μετάφραση και ανάλυση λέξεων από την τεχνητή νοημοσύνη ChatGPT
Σε αυτήν τη σελίδα μπορείτε να λάβετε μια λεπτομερή ανάλυση μιας λέξης ή μιας φράσης, η οποία δημιουργήθηκε χρησιμοποιώντας το ChatGPT, την καλύτερη τεχνολογία τεχνητής νοημοσύνης μέχρι σήμερα:
- πώς χρησιμοποιείται η λέξη
- συχνότητα χρήσης
- χρησιμοποιείται πιο συχνά στον προφορικό ή γραπτό λόγο
- επιλογές μετάφρασης λέξεων
- παραδείγματα χρήσης (πολλές φράσεις με μετάφραση)
- ετυμολογία
Τι (ποιος) είναι yet yet? - ορισμός
ALBUM BY DO MAKE SAY THINK
And Yet and Yet; & yet & yet; &yet&yet
yet yet?
The way that we refined southerners ask a friend if he has already dined.
Yet yet?
Yet yet?
Yet another
IDIOMATIC QUALIFIER USED IN THE NAME OF PROGRAMS
Yet Another; YAAP
Among programmers, yet another (often abbreviated ya, Ya, or YA in the initial part of an acronym) is an idiomatic qualifier in the name of a computer program, organisation, or event that is confessedly unoriginal.
Yet Another
IDIOMATIC QUALIFIER USED IN THE NAME OF PROGRAMS
Yet Another; YAAP
<jargon> (YA-, after Unix's yacc - Yet Another
Compiler-Compiler) A humorous allusion often used in titles to
acknowledge that the topic is not original, though the content
is. As in "Yet Another AI Group" or "Yet Another {Simulated
Annealing} Algorithm". If used of others' work, it
describes something of which there are already far too many.
In hackish acronyms the "YA" prefix almost invariably expands
to Yet Another, e.g. YABA, YAUN.
[Jargon File ]
(1996-11-26)
Βικιπαίδεια
& Yet & Yet
& Yet & Yet is the third album by Canadian post-rock band Do Make Say Think. It was released on March 18, 2002 by Constellation Records.
"Chinatown" was featured on the soundtrack for Stephen Gaghan's Syriana.
Παραδείγματα από το σώμα κειμένου για yet yet?
1. There is temporary housing, but nothing permanent yet Yet six months on, some Malaysian villages hit by the tsunami are still struggling to get back on their feet.
2. So, potential sales of Azilect have risen from a quarter–billion dollars to a billion, and that‘s to start with, says Sarig (note that the drug hasn‘t been approved for the specific use of slowing the disease yet). Yet he left his recommendation for Teva at Sector Perform. (TheMarker) Advertisement Merrill Lynch sees Azilect as a "game–changer" for Teva, though its language is cagey – "Azilect (rasagaline) could be the first product shown to slow the progression of Parkinson‘s disease." Which could transform it from a niche drug into a blockbuster.